GlaxoSmithKline Plc expects to get two withdrawn drugs back on the U.S. market in the middle of this year after signing a legal agreement with regulators over a problem plant in Puerto Rico.
Europe’s biggest drugmaker said on Thursday the early return of Paxil CR and Avandamet, two key products made at the plant, should […]
‘Patients requesting specific medications can have a profound effect on physicians prescribing medications for major depression, according to a new study in the April 27 issue of JAMA.
“Spending on direct-to-consumer (DTC) advertising of prescription drugs in the United States totaled $3.2 billion in 2003,” the authors provide as background information. “Critics charge that DTC advertisements […]
‘Despite an increase in national funding, Idaho and 10 other states continue to have waiting lists for low-income HIV and AIDS patients who need help paying for prescription drugs, according to a report from the Kaiser Family Foundation and the National Alliance of State AIDS Directors.
“These are lifesaving medications,” said Lisejean Freed with the North […]
‘Canadian researchers have found that rheumatoid arthritis patients treated with anti-inflammatory drugs are 10 times less likely to develop age-related macular degeneration, the most common form of blindness in people over 55.
The study, recently published in the Neurobiology of Aging, is a joint effort between scientists at the University of British Columbia and University of […]
‘Glenmark Pharmaceuticals SA, the Swiss subsidiary of India’s Glenmark Pharmaceuticals, has signed a collaboration agreement with Japan’s Teijin Pharma Limited, a subsidiary of Teijin Limited, for a respiratory disorders product.
The two companies have entered into a collaboration agreement for Glenmark’s PDE4 inhibitor GRC 3886, which is currently in development for chronic obstructive pulmonary disorder (COPD) […]
‘PharmaCore announced that it has acquired aromatic cross coupling technology from DSM Pharma Chemicals Venlo B.V. and is now the owner of this technology. This proprietary chemistry allows a wide variety of aryl nitriles and aryl ethers to participate in cross coupling reactions to produce derivatives that are very useful in the manufacture of drugs […]
‘”One thing is clear: patients can prompt physicians to provide better care. Drug ads are one way of getting patients to prompt their physicians – but it is not the best way. When patients brought up non-commercial information they were more likely to get the correct treatment than if they brought up the drug advertisement.”
By […]
‘GlaxoSmithKline Plc and AstraZeneca Plc, Europe’s biggest and third-largest drugmakers, may say first-quarter profit rose after the companies cut expenses and increased sales of medicines for asthma and heartburn.
Glaxo’s net income probably increased 5.4 per cent to 1.09 billion pounds ($2.07 billion), the median estimate of 10 analysts surveyed by Bloomberg News. AstraZeneca may say […]
‘The EMEA has completed its review of two classes of antidepressants and concluded that they should not be used in children and adolescents except in their approved indications. An Agency committee has recommended that the drugs carry strong warnings about suicidality and hostility risks.
The review of serotonin-selective reuptake inhibitor (SSRI) and serotonin-norepinephrine reuptake inhibitor (SNRI) […]
‘French protein pharmaceuticals developer Nautilus Biotech has reported making progress on next-generation interferon gamma, having developed a set of novel molecules engineered to create an enhanced IFN-gamma.
If developed as a biopharmaceutical, this improved, highly stable version of IFN-gamma would allow less frequent injections of the drug.
The novel molecules, developed using Nautilus’ proprietary technology for protein […]